Neutrogena Oil Free Acne Wash Pink Grapefruit Foaming Scrub

Description

This oil-free acne wash is formulated with a foaming scrub that features MICRO CLEAR® technology, designed to effectively clear breakouts. It contains naturally derived grapefruit extract, which contributes to its cleansing properties. The product is a Neutrogena® salicylic acid acne treatment, packaged in a 4.2 FL. OZ. (124 mL) container. The formulation is characterized by its pink grapefruit scent, enhancing the user experience while targeting acne.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse their face twice daily. The cleansing process should begin with wetting the face. A sufficient amount of the cleanser should be applied to the hands, followed by the addition of water to create a lather. The lather should then be gently massaged onto the face to ensure effective cleansing. It is essential to rinse the face thoroughly with water after massaging to remove all residues of the cleanser.

Contraindications

There are no specific contraindications listed for this product.

It is advised to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Additionally, avoid contact with eyes; if contact occurs, flush the eyes thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation is observed, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the eyes thoroughly with water to prevent potential damage.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

In the event of contact with the eyes, patients should flush the area thoroughly with water. Additionally, if the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately. These precautions are important to ensure the safe use of the product and to mitigate potential adverse effects.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil Free Acne Wash Pink Grapefruit Foaming Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub in geriatric patients. The drug insert does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient circumstances when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

The product does not contain specific warnings or information regarding use during pregnancy. There are no stated safety concerns, contraindications, or dosage modifications related to pregnancy. Healthcare professionals should consider the absence of data when prescribing this product to pregnant patients and weigh the potential benefits against any unknown risks. Women of childbearing potential should be counseled on the lack of specific pregnancy-related information and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that skin irritation and dryness may be more likely to occur if they use another topical acne medication concurrently. Therefore, they should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. In the event of accidental contact, patients should be instructed to flush the eyes thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure that the product remains within the recommended storage conditions.

Additional Clinical Information

The product is administered topically and should be applied twice a day. It is intended for external use only, and patients are advised to avoid using it concurrently with other topical acne medications to minimize the risk of skin irritation and dryness. In the event of irritation, it is recommended to use only one topical acne treatment at a time.

Clinicians should counsel patients to avoid contact with the eyes; if contact occurs, the area should be flushed thoroughly with water. Additionally, the product should be kept out of reach of children, and if ingested, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil Free Acne Wash Pink Grapefruit Foaming Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)